Introduction: Who Should Seek Diagnostic Evaluation

If you notice unusual changes in your body, particularly those affecting your menstrual cycle or vaginal bleeding patterns, it may be time to talk with your doctor about diagnostic tests. Stage II endometrial cancer most commonly affects the endometrium, which is the inner lining of the uterus, and can extend into the cervix. Because early detection greatly improves treatment outcomes, understanding when to seek medical evaluation is essential.^[1]

Women who experience abnormal vaginal bleeding should pay close attention to these warning signs. For those who still have menstrual periods, abnormal bleeding may appear as bleeding between periods, heavier bleeding than usual, or cycles that become shorter than normal. If you have already gone through menopause, any vaginal bleeding or spotting—even a very small amount—should prompt you to contact your healthcare provider right away.^[1]

Additional symptoms that warrant medical attention include lower abdominal pain or cramping in the pelvic area, just below your belly. Some women also notice thin white or clear vaginal discharge after menopause. If you are over 40 years old and experience extremely prolonged, heavy, or frequent vaginal bleeding, this is another important reason to schedule a diagnostic evaluation.^[1]

According to the National Cancer Institute, approximately 66.8 percent of endometrial cancers are identified at the localized stage, meaning the cancer remains confined to the uterus and has not spread to nearby tissues. This statistic highlights the importance of early diagnostic efforts, as catching the cancer while it is still within the uterus offers the best chance for successful treatment.^[10]

Diagnostic Methods for Stage II Endometrial Cancer

When you visit your doctor with symptoms that might suggest endometrial cancer, they will begin with a thorough evaluation to determine the cause of your symptoms. The diagnostic process involves several steps, starting with simpler examinations and potentially progressing to more specialized tests if needed.^[4]

Physical Examination and Pelvic Exam

The first step in diagnosing endometrial cancer typically involves a pelvic exam. During this examination, your healthcare provider carefully inspects the outer genital area. They will insert two gloved fingers into the vagina while simultaneously pressing on your abdomen with the other hand. This technique allows them to feel your uterus and ovaries to check for any abnormalities in size, shape, or texture.^[15]

A device called a speculum is also inserted into the vagina during the pelvic exam. The speculum gently opens the vaginal canal so that your doctor can visually examine the cervix and vaginal walls for signs of cancer or other problems. While a pelvic exam alone cannot definitively diagnose endometrial cancer, it provides important initial information and may reveal signs that warrant further investigation.^[15]

Transvaginal Ultrasound

If your doctor suspects endometrial cancer based on your symptoms or pelvic exam findings, they may recommend a transvaginal ultrasound. This imaging test uses sound waves to create detailed pictures of your pelvic organs. During the procedure, a healthcare professional or technician inserts a wand-like device called a transducer into your vagina while you lie on your back on an examination table.^[15]

The transducer emits sound waves that bounce off the tissues inside your body and return to create images. This test can show the thickness of the endometrial lining and help identify any abnormal growths or masses within the uterus. A thickened endometrial lining may suggest the presence of cancer or other conditions that need further evaluation. The transvaginal ultrasound is non-invasive and typically causes minimal discomfort.^[1]

Endometrial Biopsy

To confirm a diagnosis of endometrial cancer, your doctor will need to examine a sample of tissue from your uterine lining under a microscope. This procedure is called an endometrial biopsy, and it is one of the most reliable ways to diagnose endometrial cancer. During the biopsy, a thin tube is inserted through the cervix into the uterus to collect a small amount of endometrial tissue.^[4]

The tissue sample is then sent to a laboratory where a specialist called a pathologist examines it for cancer cells. The pathologist can determine not only whether cancer is present, but also what type of endometrial cancer it is and how aggressive the cancer cells appear. This information is crucial for planning treatment and predicting outcomes.^[4]

Hysteroscopy

In some cases, your doctor may recommend a procedure called hysteroscopy to get a direct view inside your uterus. During hysteroscopy, a thin, lighted tube with a camera on the end—called a hysteroscope—is inserted through the vagina and cervix into the uterus. This allows your doctor to visually examine the endometrial lining and identify any abnormal areas.^[15]

If suspicious areas are seen during hysteroscopy, your doctor can take tissue samples (biopsies) from these specific locations for further testing. Hysteroscopy provides more detailed information than other diagnostic methods and can help identify the exact location and extent of any abnormal tissue growth within the uterus.^[15]

Understanding Staging Systems

Once endometrial cancer is confirmed, doctors use a process called staging to determine how far the cancer has spread. Staging is a critical part of diagnosis because it helps your healthcare team decide on the best treatment approach. Two main staging systems are used for endometrial cancer: the American Joint Committee on Cancer TNM system and the International Federation of Gynecology and Obstetrics FIGO system.^[1]

These systems evaluate three key pieces of information about your cancer, using the acronym TNM. The “T” stands for tumor size and location, describing how big the tumor is and where it has spread within the uterus. The “N” indicates whether the cancer has spread to nearby lymph nodes—small immune system structures that can trap cancer cells. The “M” refers to metastasis, which means the cancer has spread to distant parts of the body beyond the uterus and nearby lymph nodes.^[10]

In stage II endometrial cancer, the cancer has grown into the cervix but has not spread outside the womb. The cancer may have spread from the main part of the uterus into the deeper muscle layers called the myometrium, or into the supportive connective tissue in the cervix known as the cervical stroma. However, in stage II disease, the cancer remains confined to the uterus and cervix and has not yet reached other organs or distant lymph nodes.^[2]

Substages of Stage II Endometrial Cancer

Stage II endometrial cancer is further divided into substages—A, B, and C—based on how aggressive the cancer cells appear and exactly where the cancer has spread. Substage A represents the least severe form, while substage C indicates more aggressive disease. Understanding these distinctions helps doctors create a more precise treatment plan tailored to your specific situation.^[1]

Stage 2A is characterized by nonaggressive cancer—meaning cancer cells that grow and spread slowly—that has extended to the uterus and the surface of the cervix. Stage 2B involves nonaggressive cancer that has either spread to the deeper layers of the cervix or shows cancer cells outside the main tumor. Stage 2C describes aggressive cancer—cancer that grows and spreads quickly—that has invaded the myometrium, the muscular wall of the uterus.^[10]

Additional Imaging Tests

After confirming the diagnosis of endometrial cancer, your doctor may order additional imaging tests to determine the exact stage and to check whether the cancer has spread beyond the uterus and cervix. These tests help create a complete picture of your disease and guide treatment decisions.^[4]

A computed tomography (CT) scan uses X-rays to create detailed cross-sectional images of your abdomen and pelvis. This test can show whether cancer has spread to lymph nodes or other organs in the pelvic area. Similarly, magnetic resonance imaging (MRI) uses powerful magnets and radio waves to produce highly detailed images of soft tissues, including the uterus, cervix, and surrounding structures. MRI is particularly useful for evaluating the depth of cancer invasion into the uterine wall.^[4]

In some cases, your doctor may recommend a chest X-ray to check whether cancer has spread to the lungs. These imaging tests are typically painless and performed on an outpatient basis. The information they provide is essential for accurate staging and treatment planning.^[4]

Diagnostics for Clinical Trial Qualification

If you are considering participating in a clinical trial for stage II endometrial cancer, you will undergo specific diagnostic tests to determine whether you meet the eligibility criteria for the study. Clinical trials have strict requirements about who can participate, and these requirements are based on the stage of your cancer, the type of cancer cells, and other health factors.^[4]

Most clinical trials for endometrial cancer require confirmation of your cancer diagnosis through tissue biopsy and pathology examination. The pathology report must clearly identify the type of endometrial cancer you have and confirm the stage of disease. Researchers need this precise information to ensure that all participants in the study have similar disease characteristics, which makes the results of the trial more reliable and meaningful.^[4]

Staging information is particularly important for clinical trial enrollment. You will typically need imaging studies such as CT scans or MRI to document the extent of your cancer and confirm that it meets the stage II criteria specified in the trial protocol. Some trials may also require blood tests to assess your overall health status and organ function, particularly if the trial involves testing new drug treatments that could affect the liver or kidneys.^[4]

Clinical trials may also have specific requirements regarding previous treatments. Some studies only accept patients who have not yet received any treatment for their cancer, while others may be designed for patients whose cancer has returned after initial treatment. Your medical team will review your complete medical history and all diagnostic test results to determine which clinical trials, if any, might be appropriate for you.^[4]

Genetic testing may be required for certain clinical trials, particularly those investigating targeted therapies. Some endometrial cancers are associated with specific genetic changes or mutations that make them more likely to respond to certain treatments. If you have a family history of endometrial cancer or certain genetic conditions such as Lynch syndrome, your doctor may recommend genetic testing as part of your diagnostic evaluation.^[4]